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ABSTRACT
Objective To study the impact of resting heart rate
and leisure time physical activity at middle age on long
term risk of drug treated lone atrial ﬁbrillation (AF).
Design Longitudinal cohort study of 309 540
Norwegian men and women aged 40–45 years
examined during 1985–1999 followed from 2005
through 2009.
Setting Data from a national health screening
programme were linked to the Norwegian Prescription
Database (NorPD).
Patients The cohort comprised 162 078 women and
147 462 men; 575 (0.4%) men and 288 women (0.2%)
received ﬂecainide and 568 men and 256 women
sotalol and were deﬁned as patients with AF.
Interventions No interventions.
Main outcome measures The outcome was lone
ﬁbrillation deﬁned by having at least one prescription of
ﬂecainide or sotalol registered in NorPD between 2005
and 2009. Cox proportional hazard regression models
were used to assess time to ﬁrst prescription.
Results The risk for being prescribed these drugs
increased with decreasing baseline resting heart.
Adjusted hazard ratio (HR) per 10 beats/min decrease in
resting heart rate for ﬂecainide prescription was 1.26 in
men (95% CI 1.17 to 1.35) and 1.15 (95% CI 1.05 to
1.27) in women. Similar effects were seen for sotalol in
men, but not in women. Men who reported intensive
physical activity were more often prescribed ﬂecainide
than those in the sedentary group (adjusted HR=3.14,
95% CI 2.17 to 4.54).
Conclusions This population based study supports the
hypothesis that the risk of drug treated lone AF increases
with declining resting heart rate in both sexes, and with
increasing levels of self-reported physical activity in men.
INTRODUCTION
The majority of atrial ﬁbrillation (AF) cases occurs
among patients who have concomitant cardiovascu-
lar disease: hypertension, a history of heart failure,
coronary artery disease, or valvular pathology.1
Physical exercise is an important measure to
prevent these diseases. There are, however, a
number of AF cases that lack evidence of structural
heart disease—the patients with ‘lone AF’. These
have a fair long term prognosis,2 and clearly differ
from the general AF population.
In 1998, a Finnish study of high ranking male
orienteers showed an association between exercise
and AF.3 Several subsequent studies have conﬁrmed
these results by comparing the prevalence of AF in
top athletes versus various control groups.4 5 The
ﬁndings of two population based cohort studies,6 7
which more likely reﬂect the general population,
were less consistent. The American Physicians’
Health study, comprising 16 921 healthy men ori-
ginally recruited from among more than 200 000
American physicians, suggested a dose–response
relationship between strenuous physical activity and
risk of AF. The risk of AF increased by >50%
among high intensity exercisers aged below 50
years.6 However, another US cohort comprising
members of Medicare aged above 65 years did not
show any signiﬁcantly increased risk of AF with
increasing levels of physical activity.7 A review of
this topic from 1995 to 2011 showed that many of
the previous studies are not directly comparable
because of different deﬁnitions of physical activity
and AF, and differences in study design and popula-
tion composition.8 The most recent reviews, by
Delise et al as well as Müller-Riemenschneider
et al,9 10 critiqued the published studies on sport
practice and AF. They concluded that there is no
evidence to suggest an increased risk of AF in sub-
jects with normal hearts. The evidence of resting
heart rate, in addition to ﬁtness, as a predictor of
total mortality adds to this heterogeneity.11 The
purpose of the present study was to investigate the
impact both of resting heart rate and self-reported
leisure time physical activity on the risk of lone AF
in the general population, based on data linkage
between the nationwide age-40 programme with
more than 300 000 Norwegian men and women
and the Norwegian Prescription Database (NorPD)
using the prescription of ﬂecainide or sotalol as
proxy for paroxysmal and persistent lone AF.
METHODS
The age-40 programme
From 1985 to 1999, Norwegian health authorities
conducted a screening programme among women
and men aged 40–42 years in 18 Norwegian coun-
ties. The programme was based on regular visits by
a health examination team to all municipalities,
every third year. All residents aged 40–42 years
were invited, and a few counties also included a
broader age range.
Details on study procedures have been published
previously.12 Height, weight, resting heart rate, and
blood pressure were measured. Participants were
also asked to ﬁll out a questionnaire about their
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lifestyle and previous and current illness. All surveys were
carried out by trained personnel from the National Health
Screening Service, now incorporated into the Norwegian
Institute of Public Health. Information about education was
obtained from Statistics Norway (http://www.ssb.no/en/), while
information on medication was retrieved from NorPD via
record linkage using the 11 digit encrypted unique person iden-
tiﬁcation number assigned to all persons living in
Norway.13 Record linkage was approved by the Norwegian Data
Inspectorate and the Regional Committee for Medical Research
Ethics.
Study sample
Our main study sample comprised men and women aged 40–
45 years at the time of screening (1985–1999), with valid infor-
mation on resting heart rate and relevant covariates such as
height and weight, level of education and self-reported smoking
habits, and with no registered prescription of ﬂecainide or
sotalol in 2004. We performed additional analyses including
only the 233 784 ‘heart healthy’ individuals reporting no car-
diovascular disease at screening (ie, self-reported previous myo-
cardial infarction or angina pectoris) and with no cardiovascular
prescription drugs dispensed in 2004.
Exposure
The main exposure variables were resting heart rate recorded at
baseline and self-reported level of leisure time physical activity.
Resting heart rate, and systolic and diastolic blood pressures
were assessed by DINAMAP (Criticon, Tampa, USA), which
measured the blood pressure and heart rate automatically by an
oscillometric method. After 2 min of rest, three recordings were
made at 1 min intervals. Mean values of the second and third
measurements were used in the present study. Participants were
asked to tick ‘YES’ on the questionnaire beside the most ﬁtting
description of their leisure time physical activity level. If activity
varied a lot—for example, between summer and winter—they
were asked to give an average covering the previous 12 months.
The four mutually exclusive response categories were:
A. Sedentary: reading, watching TV, or other sedentary activity
B. Moderate: walking, cycling, or other forms of exercise at
least 4 h per week (including walking or cycling to the work-
place, Sunday walking, etc)
C. Intermediate: participation in recreational sports, heavy gar-
dening or similar activities for at least 4 h per week
D. Intensive: Participation in hard training or sports competi-
tions, regularly and several times per week.
Health outcomes
The main outcome was paroxysmal or persistent lone AF
deﬁned as having at least one prescription of ﬂecainide or
sotalol registered in NorPD between 1 January 2005 and the
end of the follow-up in 31 December 2009. NorPD includes
prescription data from the entire population in Norway since
2004. It contains information on all prescriptions dispensed at
pharmacies, regardless of whether they were reimbursed or not.
Patient identity is strictly protected through encryption. The
drugs are classiﬁed according to the Anatomical Therapeutic
Chemical (ATC) classiﬁcation system.14 Data included in the
present analyses are: the patient’s unique identifying number
(encrypted), sex, age, date of dispensing, and drug information
(ATC code). Information on dispensing of ﬂecainide (ATC code
C01BC04), sotalol (C07AA07), and other cardiovascular drugs
(ATC group C) was included.
Other variables
Based on their potential status as risk factors for AF, and also
because they are factors that may inﬂuence resting heart rate
and level of leisure time physical activity, we included the fol-
lowing variables measured or registered at the time of screening
as confounders: self-reported previous myocardial infarction or
angina pectoris, body height, body mass index (measured as kg/
m2), daily smoking (yes/no), education (low: primary or lower
secondary; middle: higher secondary or high school; high: uni-
versity/college), and age (years). We also included year of screen-
ing in the model. Bodyweight in kg and height in cm were
measured according to a standard protocol. The possible con-
founding effect of underlying cardiovascular disease was further
adjusted for in the analyses by including use of cardiovascular
medicine during 2004 as an indicator in the multivariate model.
We also performed separate secondary analyses of the ‘heart
healthy’ group by excluding participants with self-reported pre-
vious myocardial infarction or angina pectoris or with at least
one cardiovascular prescription drug (ATC group C) dispensed
in 2004.
Statistics
In all analyses, we studied ‘new’ users of ﬂecainide or sotalol,
deﬁned as patients who had no prescription of these drugs in
2004. In the ﬁrst analysis, the time from 1 January 2005 to ﬁrst
prescription of ﬂecainide was the outcome, whereas in a second-
ary analysis the time to ﬁrst prescription of sotalol was used.
The Cox model was used to model the association with resting
heart rate and leisure time physical activity. The analyses were
run for the two genders separately. When testing for interaction
with gender, both genders were included in the model.
Participants were censored at time of death, emigration or end
of follow-up by 31 December 2009, whichever came ﬁrst. Dates
of death and emigration were obtained from the National
Population Register.
RESULTS
The total number of individuals who participated in the screen-
ing was 417 336. Participation rate declined over time, from
81% in 1985 to 52% in 1999, with an average participation
rate of 70% for the entire period. Our main study sample con-
sisted of 147 462 men and 162 078 women (ﬁgure 1). There
were 233 784 ‘heart healthy’ individuals. The average age at
screening was 41.4 years in our study population. Table 1 shows
the baseline characteristics of the participating men and women,
and the distribution of possible confounders. Women had a
lower frequency of intensive and intermediate leisure time phys-
ical activity and a higher heart rate than men.
A total of 575 (0.4%) men and 288 (0.2%) women were pre-
scribed ﬂecainide for the ﬁrst time during follow-up (table 2).
The risk of being prescribed ﬂecainide increased gradually with
decreasing heart rate in both genders. The crude hazard rate per
each 10 beats/min decrease in heart rate was 1.29 in men and
1.12 in women. In a model including both genders a statistically
signiﬁcant interaction with gender was found (p=0.02). The
hazard ratios remained virtually unchanged after adjustment for
potential confounding variables. Restricting the sample to the
‘heart healthy’ gave similar results for ﬂecainide among men.
The risk of being prescribed sotalol showed a weaker associ-
ation with resting heart rate, with an adjusted hazard ratio of
1.12 in men and no association in women.
There was also a decline in heart rate with increasing level of
leisure time physical activity; 76, 74, 69, and 62 beats/min in
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the various activity categories among men, and 79, 77, 74, and
69 beats/min among women. The percentage of ﬂecainide users
increased gradually by increasing level of physical activity in
men (table 3; p value for trend <0.001). No such association
was seen in women. Adjustment for covariates had a minor
impact on hazard ratios for leisure time physical activity among
men. Men reporting intensive activity were also at increased risk
of using sotalol (data not shown).
The effect estimate for heart rate remained virtually
unchanged when adjusting for physical activity in men, from
1.26 to 1.21, whereas adjusting for heart rate on the effect of
physical activity reduced the estimate for intensive activity from
3.14 to 2.54.
DISCUSSION
This population based longitudinal study showed that the risk of
being prescribed ﬂecainide—an antiarrhythmic drug mainly
used for prevention of recurrence of lone AF—increased with
decreasing resting heart rate, both in men and women. The risk
of being prescribed ﬂecainide also increased with increasing
level of self-reported leisure time physical activity among men.
The ﬁndings are robust and remained unaffected by adjustment
for several confounding factors.
The present study is as far as we know the ﬁrst study to
analyse both heart rate and level of leisure time physical activity
as risk factors for AF. Our results suggest that low resting heart
rate and high physical activity are both associated with AF
without structural heart disease.
A number of studies suggest that athletes are more prone to
AF, although some controversies exist.3–9 The differing conclu-
sions in the literature on the relationship between endurance
physical activity and AF8 9 may be due to heterogeneity of the
study populations. To avoid such confusion we restricted our AF
cases to middle-aged people with lone AF.
The present data does not permit analysis of pathophysio-
logical mechanisms. However, a likely causal chain is that phys-
ical activity is related to heart rate, and that lower resting heart
Figure 1 Flowchart showing the
total number of participants in the
screening 1985 to 1999, and the
subsequent exclusions ending with
309 540 subjects aged 46–62 at start
of follow-up, and eligible for the
present analysis. CVD, cardiovascular
disease.
Table 1 Baseline characteristics of 147 462 men and 162 078
women aged 40–45 years at screening (age 46–62 years at
1 January 2005)
Men Women
Age at screening: mean (SD) 41.4 (1.1) 41.4 (1.0)
Age 1 January 2005 (start of follow-up):
mean (SD)
54.2 (3.8) 54.1 (3.8)
Year of screening: mean (SD) 1992 (3.6) 1992 (3.7)
Heart rate (beats/min): mean (SD) 72.6 (12.7) 77.3 (12.6)
Systolic blood pressure (mm Hg): mean (SD) 133.8 (13.5) 124.4 (14.2)
Diastolic blood pressure (mm Hg): mean (SD) 80.3 (9.8) 75.6 (10.0)
Height (cm): mean (SD) 179.0 (6.4) 165.8 (5.8)
Weight (kg): mean (SD) 82.3 (11.7) 66.9 (11.4)
BMI (kg/m2): mean (SD) 25.7 (3.2) 24.3 (3.9)
Physical activity: number (%)
Sedentary 29 275 (19.9) 30 372 (18.7)
Moderate 76 910 (52.2) 113 658 (70.1)
Intermediate 37 092 (25.2) 16 850 (10.4)
Intensive 4185 (2.8) 1198 (0.7)
Married: number (%) 113 491 (77.0) 127 610 (78.7)
Education: number (%)
Low (primary or lower secondary school) 23 738 (16.1) 29 629 (18.3)
Middle (higher secondary or high school) 80 748 (54.8) 91 336 (56.4)
High (university/college) 42 976 (29.1) 41 113 (25.4)
Daily smoking: number (%) 59 551 (40.4) 65 491 (40.4)
CVD at baseline: number (%) 1412 (1.0) 665 (0.4)
Cardiovascular drugs in 2004: number (%) 37 590 (25.5) 37 294 (23.0)
BMI, body mass index; CVD, cardiovascular disease.
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rate increases the risk of lone AF. Adjusting for heart rate on
the effect of physical activity in men reduced the estimates,
which is to be expected. This corresponds with Grundvold et al
who recently demonstrated that among presumably healthy
middle-aged men, a heart rate of <100 beats/min during a
100 W exercise load conferred a 60% higher risk for future AF
compared to those who attained faster heart rates at this low
exercise load (personal communication, 2013). In a recent ana-
lysis from the Copenhagen Study where the emphasis was risk
of death associated with resting heart rate, they adjusted for
ﬁtness, but not the other way around.11 In our study the effect
of heart rate was only slightly reduced when taking physical
activity into account, suggesting that heart rate is closer to the
pathophysiological mechanism.
Patient groups with lone paroxysmal and persistent AF are
heterogeneous; some have arrhythmia mainly at rest, others
upon adrenergic stimulation during exercise, and many have no
distinct pattern. The balance between parasympathetic and sym-
pathetic activity is considered to be involved both in the
initiation and maintenance of AF, as supported by the fact that
catheter ablation targeting intrinsic cardiac ganglia may increase
the success rate of AF ablation.15 An increased vagal tone short-
ens the atrial refractory period facilitating re-entry circuits in the
atria, and bradycardia increases stroke volume, augments
myocyte stretch and facilitates increased automaticity, all favour-
ing AF induction.16
The major weaknesses of our study are the use of drug treat-
ment as proxy for AF, and the fact that heart rate and physical
activity were only assessed at one point in time and with a con-
siderable time lag between health examinations and start of
follow-up. From the NorPD we ﬁnd that 65–70% of the sotalol
and ﬂecainide prescriptions are attributed to AF and/or ﬂutter,
25% to ‘arrhythmia not otherwise classiﬁed’, and the rest to
paroxysmal tachycardia. The potential misclassiﬁcation most
likely underestimates the effects.
In Norway, the drugs used for rhythm control of AF in the
study period include ﬂecainide, sotalol, disopyramide, and
amiodarone. The prescription of disopyramide is minimal
Table 2 Hazard ratios for first time use of flecainide and first time use of sotalol during 2005–2009, per 10 beats/min decrease in resting heart
rate measured at baseline in 147 462 men and 162 078 women aged 40–45 years
Users Crude Model 1* Model 2
End point/group N n (%) HR 95% CI HR 95% CI HR 95% CI
First time use of flecainide:
Men 147 462 575 (0.4) 1.29 1.20 1.38 1.27 1.18 1.36 1.26† 1.17 1.35
Women 162 078 288 (0.2) 1.12 1.02 1.23 1.13 1.03 1.25 1.15† 1.05 1.27
First time use of flecainide:
‘Heart healthy’ men 109 350 367 (0.3) 1.28 1.17 1.40 1.25 1.15 1.37 1.23‡ 1.12 1.35
‘Heart healthy’ women 124 434 151 (0.1) 1.07 0.94 1.23 1.08 0.94 1.24 1.07‡ 0.93 1.23
First time use of sotalol:
Men 147 462 568 (0.4) 1.04 0.98 1.12 1.09 1.02 1.16 1.12† 1.04 1.20
Women 162 078 256 (0.2) 0.95 0.86 1.05 0.98 0.89 1.08 1.00† 0.91 1.10
Separate analyses of first time use of flecainide in the subgroups of 109 350 ‘heart healthy’ men and 124 434 ‘heart healthy’ women.
*Adjusted for age 2005, year of screening, education, body mass index (BMI), and height.
†Adjusted for age 2005, year of screening, education, BMI, height, daily smoking, self-reported cardiovascular disease at screening, and dispensed cardiovascular drug in 2004.
‡Adjusted for age 2005, year of screening, education, BMI, height, and daily smoking.
Table 3 Hazard ratios for first time use of flecainide during 2005-2009 among 162 078 women and 147 462 men aged 40–45 years, by leisure
time physical activity at baseline
Users Crude Model 1* Model 2†
N n % HR 95% CI HR 95% CI HR 95% CI
Men
Physical activity
Sedentary 29 275 89 0.3 1 ref 1 ref 1 ref
Moderate 76 910 273 0.4 1.16 0.92 1.48 1.13 0.89 1.44 1.12 0.88 1.42
Intermediate 37 092 169 0.5 1.49 1.15 1.93 1.40 1.08 1.81 1.36 1.05 1.77
Intensive 4185 44 1.0 3.44 2.40 4.94 3.31 2.30 4.76 3.14 2.17 4.54
Total 147 462 575 0.4
Women
Physical activity
Sedentary 30 372 58 0.2 1 ref 1 ref 1 ref
Moderate 113 658 203 0.2 0.93 0.70 1.25 0.94 0.70 1.26 0.96 0.71 1.29
Intermediate 16 850 27 0.2 0.84 0.53 1.32 0.83 0.52 1.31 0.87 0.55 1.38
Intensive 1198 0 0.0
Total 162 078 288 0.2
*Adjusted for age 2005, year of screening, education, body mass index (BMI), and height.
†Adjusted for age 2005, year of screening, education, BMI, height, daily smoking, self-reported cardiovascular disease at screening, and dispensed cardiovascular drugs in 2004.
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(<3% of all patients using class I antiarrhythmics13), and amio-
darone is little used for lone AF. The access to catheter ablation
for AF was limited in the study period. Flecainide has proar-
rhythmic effects that may increase mortality in patients with
structural heart disease, and is therefore contraindicated in
patients with underlying heart disease.17 In Norway, this drug
treatment must be initiated by a specialist in internal medicine
or cardiology. Consequently, almost only lone AF patients will
be prescribed ﬂecainide.
Sotalol is a non-selective β-adrenoreceptor blocking agent
with both class II and class III antiarrhythmic properties. Its
main indication is also prevention of recurrent AF, which has
been best documented in patients with concomitant coronary
heart disease, but the drug also has some use in the treatment of
ventricular arrhythmias. Hence the sotalol group is less pure
with respect to lone AF. This ﬁts well with our observation that
the relationship between exercise and drug use was stronger for
ﬂecainide than for the sotalol group.
The NorPD covers the entire Norwegian population, and all
those having these drugs dispensed during the follow-up period
were registered. The outcomes are thus virtually complete. In
our main analysis, we excluded 1177 subjects with prevalent use
of ﬂecainide or sotalol in 2004, in order to capture only new
cases of drug treated AF as the outcome. We did, however,
include these subjects in an additional analysis (data not shown),
and the results were similar to those reported in this paper. We
do not know the extent to which our estimates are affected by
the lack of inclusion of cases with asymptomatic AF and those
who had symptoms, but who did not seek medical advice in
Norway. Physically active individuals might more often seek
medical advice for symptoms of AF. However, active people
might also prefer to avoid the ‘sick role’ and medication.
Because ﬂecainide only modestly reduces heart rate and does
not affect exercise capacity, it is the preferred drug among phys-
ically active AF patients.18 However, using sotalol as the
outcome gave similar results.
Heart rate was measured in a standardised way in all studies
using the same staff and equipment.12 Repeated heart rate mea-
surements at 10 year interval have been shown to be relatively
strongly correlated,19 supporting the use of one single assess-
ment even after a long time interval. The physical activity ques-
tionnaire was developed by Swedish physiologists during the
1960s.20 21 This questionnaire has shown consistent validity
over time, also in terms of its predictive power for chronic dis-
orders as varied as coronary heart disease and breast
cancer.22–24 Furthermore, level of physical activity at baseline
was associated with resting heart rate. Similar relations between
resting heart rate and physical exercise capacity have also been
described previously.25 Tracking of physical activity was assessed
in the Tromsø study, where repeated examinations after 7 and
28 years showed that a higher than expected proportion of sub-
jects maintained their physical activity level.26 Being physically
active in young adulthood increased the odds of being physically
active later in life. We therefore conclude that even if physical
activity levels and resting pulse are measured only at baseline
and may change over time, this is more likely to underestimate
the effects than to create other systematic errors.
The lack of an association between leisure time physical activ-
ity and AF in women is intriguing, but the ﬁnding may be due
to lack of power since we had few female cases. This is sup-
ported by the consistent ﬁnding regarding heart rate and lone
AF in the two genders. The clearly lower effect estimates in
women than men also suggest that there are physiological and
anatomical differences—for example, in heart size—that may
inﬂuence the risk of AF as well as clinical presentation.27 28
The major strengths of this population based study are: (1) the
total coverage of the study population via the NorPD, which
secures a complete follow-up regarding the deﬁned outcome
variables; (2) the magnitude of the study cohort with high attend-
ance rate and its longitudinal design; and (3) standardised infor-
mation on the exposure and possible confounding factors.
This population based study supports the hypothesis that the
risk of drug treated lone AF increases with declining resting
heart rate in both sexes, and with increasing level of self-
reported physical activity in men. Future studies should devote
more attention to training frequency, duration, intensity, the
type and total volume of training, as well as vulnerable age
periods and genetic vulnerability as plausible risk factors.29 30
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